A monoclonal gammopathy precedes multiple myeloma in most patients
Top Cited Papers
Open Access
- 28 May 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (22), 5418-5422
- https://doi.org/10.1182/blood-2008-12-195008
Abstract
Preexisting plasma cell disorders, monoclonal gammopathy of undetermined significance, or smoldering myeloma are present in at least one-third of multiple myeloThis publication has 24 references indexed in Scilit:
- Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disordersBritish Journal of Haematology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myelomaBlood, 2008
- Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple MyelomaThe New England Journal of Medicine, 2007
- Gene-expression signature of benign monoclonal gammopathy evident in multiple myeloma is linked to good prognosisBlood, 2006
- Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significanceBlood, 2005
- Review of 1027 Patients With Newly Diagnosed Multiple MyelomaMayo Clinic Proceedings, 2003
- Multiple myeloma: evolving genetic events and host interactionsNature Reviews Cancer, 2002
- A Long-Term Study of Prognosis in Monoclonal Gammopathy of Undetermined SignificanceThe New England Journal of Medicine, 2002
- IgD monoclonal gammopathy with long‐term follow‐upBritish Journal of Haematology, 1994